220 related articles for article (PubMed ID: 19874561)
1. Periods without agitation diminish platelet mitochondrial function during storage.
Skripchenko A; Myrup A; Thompson-Montgomery D; Awatefe H; Moroff G; Wagner SJ
Transfusion; 2010 Feb; 50(2):390-9. PubMed ID: 19874561
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunction of platelets stored in first- and second-generation containers is, in part, associated with elevated carbon dioxide levels.
Skripchenko A; Myrup A; Thompson-Montgomery D; Awatefe H; Wagner SJ
Transfusion; 2011 Feb; 51(2):371-9. PubMed ID: 20796252
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the in vitro properties of apheresis platelets during 7-day storage after interrupting agitation for one or three periods.
Wagner SJ; Vassallo R; Skripchenko A; Einarson M; Seetharaman S; Moroff G
Transfusion; 2008 Dec; 48(12):2492-500. PubMed ID: 18764829
[TBL] [Abstract][Full Text] [Related]
4. The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage.
Wagner SJ; Vassallo R; Skripchenko A; Einarson M; Seetharaman S; Moroff G
Transfusion; 2008 Jun; 48(6):1072-80. PubMed ID: 18373503
[TBL] [Abstract][Full Text] [Related]
5. Maintenance of platelet in vitro properties during 7-day storage in M-sol with a 30-hour interruption of agitation.
Wagner SJ; Myrup A; Awatefe H; Thompson-Montgomery D; Hirayama J; Skripchenko A
Transfusion; 2008 Dec; 48(12):2501-607. PubMed ID: 18764828
[TBL] [Abstract][Full Text] [Related]
6. A rest period before agitation may improve some in vitro apheresis platelet parameters during storage.
Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Wagner SJ
Transfusion; 2012 Jul; 52(7):1433-8. PubMed ID: 22211457
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.
Li J; Lockerbie O; de Korte D; Rice J; McLean R; Goodrich RP
Transfusion; 2005 Jun; 45(6):920-6. PubMed ID: 15934990
[TBL] [Abstract][Full Text] [Related]
8. Influence of apheresis container size on the maintenance of platelet in vitro storage properties after a 30-h interruption of agitation.
Wagner SJ; Skripchenko A; Seetharaman S; Myrup A; Kurtz J; Thomas-Montgomery D; Awatefe H; Moroff G
Transfus Apher Sci; 2010 Aug; 43(1):9-15. PubMed ID: 20554476
[TBL] [Abstract][Full Text] [Related]
9. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
[TBL] [Abstract][Full Text] [Related]
10. Interruption of agitation of platelet concentrates: a multicenter in vitro study by the BEST Collaborative on the effects of shipping platelets.
Dumont LJ; Gulliksson H; van der Meer PF; Murphy S; Nixon JG; de Wildt-Eggen J; Vandenbroeke T; Aubuchon JP
Transfusion; 2007 Sep; 47(9):1666-73. PubMed ID: 17725732
[TBL] [Abstract][Full Text] [Related]
11. Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies.
Picker SM; Schneider V; Oustianskaia L; Gathof BS
Transfusion; 2009 Nov; 49(11):2311-8. PubMed ID: 19624608
[TBL] [Abstract][Full Text] [Related]
12. High-yield platelet units revealed immediate pH decline and delayed mitochondrial dysfunction during storage in 100% plasma as compared with storage in SSP+.
Sandgren P; Stjepanovic A
Vox Sang; 2012 Jul; 103(1):55-63. PubMed ID: 22220692
[TBL] [Abstract][Full Text] [Related]
13. Storing apheresis platelets without agitation with simulated shipping conditions during two separate periods: immediately after collection and subsequently between Day 2 and Day 3.
Moroff G; Kurtz J; Seetharaman S; Wagner SJ
Transfusion; 2011 Mar; 51(3):636-42. PubMed ID: 20849403
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of in vitro properties of leukoreduced whole blood-derived pooled platelets after a 24-hour interruption of agitation.
Vassallo RR; Wagner SJ; Einarson M; Nixon J; Ziegler D; Moroff G
Transfusion; 2009 Oct; 49(10):2131-5. PubMed ID: 19555418
[TBL] [Abstract][Full Text] [Related]
15. Influence of pH on stored human platelets.
Dekkers DW; De Cuyper IM; van der Meer PF; Verhoeven AJ; de Korte D
Transfusion; 2007 Oct; 47(10):1889-95. PubMed ID: 17880616
[TBL] [Abstract][Full Text] [Related]
16. Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days.
Albanyan AM; Harrison P; Murphy MF
Transfusion; 2009 Jan; 49(1):108-17. PubMed ID: 18954396
[TBL] [Abstract][Full Text] [Related]
17. Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V.
Albanyan AM; Murphy MF; Rasmussen JT; Heegaard CW; Harrison P
Transfusion; 2009 Jan; 49(1):99-107. PubMed ID: 18954406
[TBL] [Abstract][Full Text] [Related]
18. In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days.
Cookson P; Thomas S; Marschner S; Goodrich R; Cardigan R
Transfusion; 2012 May; 52(5):983-94. PubMed ID: 22014032
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.
Charania R; Smith J; Vesely SK; Dale GL; Holter J
Transfusion; 2011 Dec; 51(12):2690-4. PubMed ID: 21645004
[TBL] [Abstract][Full Text] [Related]
20. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
